Polysaccharides from Polygonatum Inhibit the Proliferation of Prostate Cancer-Associated Fibroblasts

Asian Pac J Cancer Prev. 2016;17(8):3829-33.

Abstract

Inhibition of cancer-associated broblasts (CAFs) may improve the efficacy of cancer therapy. Polysaccharide extracted from polygonatum can selectively inhibit the growth of prostate-CAFs (<.001) without inhibiting the growth of normal broblasts (NAFs). Polysaccharides from polygonatum stimulate autophagy of prostate-CAFs. 3-methyl-adenine(3-MA) is an autophagy inhibitor. 3-MA was added to prostate-CAFs with polysaccharide from polygonatum to determine whether autophagy plays an important role in the restrained effect. Finally, polysaccharide from polygonatum treatment significantly increased the activation of Beclin-1 and LC3, key autophagy proteins. Polysaccharides from polygonatum stimulate autophagy of prostate-CAFs and inhibits prostate-CAF growth, indicating that a novel anti-cancer strategy involves inhibiting the growth of prostate- CAFs.

MeSH terms

  • Apoptosis Regulatory Proteins / metabolism
  • Autophagy / drug effects
  • Cancer-Associated Fibroblasts / drug effects*
  • Cancer-Associated Fibroblasts / metabolism
  • Cell Line, Tumor
  • Cell Proliferation / drug effects*
  • Humans
  • Male
  • Membrane Proteins / metabolism
  • Plant Extracts / pharmacology
  • Polygonatum / chemistry*
  • Polysaccharides / pharmacology*
  • Prostate / drug effects
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / metabolism

Substances

  • Apoptosis Regulatory Proteins
  • Membrane Proteins
  • Plant Extracts
  • Polysaccharides